BACKGROUND: Neuropsychological deficits predate overt psychosis and overlap with the impairments in the established disease. However, to date, no single neurocognitive measure has shown sufficient power for a prognostic test. Thus, it remains to be determined whether multivariate neurocognitive pattern classification could facilitate the diagnostic identification of different at-risk mental states (ARMS) for psychosis and the individualized prediction of illness transition. METHODS: First, classification of 30 healthy controls (HC) vs 48 ARMS individuals subgrouped into 20 "early," 28 "late" ARMS subjects was performed based on a comprehensive neuropsychological test battery. Second, disease prediction was evaluated by categorizing the neurocognitive baseline data of those ARMS individuals with transition (n = 15) vs non transition (n = 20) vs HC after 4 years of follow-up. Generalizability of classification was estimated by repeated double cross-validation. RESULTS: The 3-group cross-validated classification accuracies in the first analysis were 94.2% (HC vs rest), 85.0% (early at-risk subjects vs rest), and, 91.4% (late at-risk subjects vs rest) and 90.8% (HC vs rest), 90.8% (converters vs rest), and 89.0% (nonconverters vs rest) in the second analysis. Patterns distinguishing the early or late ARMS from HC primarily involved the verbal learning/memory domains, while executive functioning and verbal IQ deficits were particularly characteristic of the late ARMS. Disease transition was mainly predicted by executive and verbal learning impairments. CONCLUSIONS: Different ARMS and their clinical outcomes may be reliably identified on an individual basis by evaluating neurocognitive test batteries using multivariate pattern recognition. These patterns may have the potential to substantially improve the early recognition of psychosis.
BACKGROUND: Neuropsychological deficits predate overt psychosis and overlap with the impairments in the established disease. However, to date, no single neurocognitive measure has shown sufficient power for a prognostic test. Thus, it remains to be determined whether multivariate neurocognitive pattern classification could facilitate the diagnostic identification of different at-risk mental states (ARMS) for psychosis and the individualized prediction of illness transition. METHODS: First, classification of 30 healthy controls (HC) vs 48 ARMS individuals subgrouped into 20 "early," 28 "late" ARMS subjects was performed based on a comprehensive neuropsychological test battery. Second, disease prediction was evaluated by categorizing the neurocognitive baseline data of those ARMS individuals with transition (n = 15) vs non transition (n = 20) vs HC after 4 years of follow-up. Generalizability of classification was estimated by repeated double cross-validation. RESULTS: The 3-group cross-validated classification accuracies in the first analysis were 94.2% (HC vs rest), 85.0% (early at-risk subjects vs rest), and, 91.4% (late at-risk subjects vs rest) and 90.8% (HC vs rest), 90.8% (converters vs rest), and 89.0% (nonconverters vs rest) in the second analysis. Patterns distinguishing the early or late ARMS from HC primarily involved the verbal learning/memory domains, while executive functioning and verbal IQ deficits were particularly characteristic of the late ARMS. Disease transition was mainly predicted by executive and verbal learning impairments. CONCLUSIONS: Different ARMS and their clinical outcomes may be reliably identified on an individual basis by evaluating neurocognitive test batteries using multivariate pattern recognition. These patterns may have the potential to substantially improve the early recognition of psychosis.
Authors: Nikolaos Koutsouleris; Katja Patschurek-Kliche; Johanna Scheuerecker; Petra Decker; Ronald Bottlender; Gisela Schmitt; Dan Rujescu; Ina Giegling; Christian Gaser; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl Journal: Schizophr Res Date: 2010-09-09 Impact factor: 4.939
Authors: Ralf Pukrop; Stephan Ruhrmann; Frauke Schultze-Lutter; Andreas Bechdolf; Anke Brockhaus-Dumke; Joachim Klosterkötter Journal: Schizophr Res Date: 2007-03-06 Impact factor: 4.939
Authors: E M Meisenzahl; N Koutsouleris; C Gaser; R Bottlender; G J E Schmitt; P McGuire; P Decker; B Burgermeister; C Born; Maximilian Reiser; H-J Möller Journal: Schizophr Res Date: 2008-04-25 Impact factor: 4.939
Authors: Christos Davatzikos; Dinggang Shen; Ruben C Gur; Xiaoying Wu; Dengfeng Liu; Yong Fan; Paul Hughett; Bruce I Turetsky; Raquel E Gur Journal: Arch Gen Psychiatry Date: 2005-11
Authors: G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger Journal: Arch Gen Psychiatry Date: 2010-02
Authors: Martin Rozycki; Theodore D Satterthwaite; Nikolaos Koutsouleris; Guray Erus; Jimit Doshi; Daniel H Wolf; Yong Fan; Raquel E Gur; Ruben C Gur; Eva M Meisenzahl; Chuanjun Zhuo; Hong Yin; Hao Yan; Weihua Yue; Dai Zhang; Christos Davatzikos Journal: Schizophr Bull Date: 2018-08-20 Impact factor: 9.306
Authors: Laura Pina-Camacho; Juan Garcia-Prieto; Mara Parellada; Josefina Castro-Fornieles; Ana M Gonzalez-Pinto; Igor Bombin; Montserrat Graell; Beatriz Paya; Marta Rapado-Castro; Joost Janssen; Inmaculada Baeza; Francisco Del Pozo; Manuel Desco; Celso Arango Journal: Eur Child Adolesc Psychiatry Date: 2014-08-11 Impact factor: 4.785
Authors: Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie Journal: World Psychiatry Date: 2014-10 Impact factor: 49.548
Authors: Nikolaos Koutsouleris; Lana Kambeitz-Ilankovic; Stephan Ruhrmann; Marlene Rosen; Anne Ruef; Dominic B Dwyer; Marco Paolini; Katharine Chisholm; Joseph Kambeitz; Theresa Haidl; André Schmidt; John Gillam; Frauke Schultze-Lutter; Peter Falkai; Maximilian Reiser; Anita Riecher-Rössler; Rachel Upthegrove; Jarmo Hietala; Raimo K R Salokangas; Christos Pantelis; Eva Meisenzahl; Stephen J Wood; Dirk Beque; Paolo Brambilla; Stefan Borgwardt Journal: JAMA Psychiatry Date: 2018-11-01 Impact factor: 21.596